3-124228048-G-A

Variant summary

Our verdict is Benign. The variant received -11 ACMG points: 0P and 11B. BP4BP6BP7BA1

The NM_001388419.1(KALRN):​c.132G>A​(p.Lys44Lys) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0604 in 1,613,456 control chromosomes in the GnomAD database, including 4,897 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (no stars).

Frequency

Genomes: 𝑓 0.099 ( 1132 hom., cov: 31)
Exomes 𝑓: 0.056 ( 3765 hom. )

Consequence

KALRN
NM_001388419.1 synonymous

Scores

2

Clinical Significance

Benign no assertion criteria provided B:1

Conservation

PhyloP100: 3.01

Publications

10 publications found
Variant links:
Genes affected
KALRN (HGNC:4814): (kalirin RhoGEF kinase) Huntington's disease (HD), a neurodegenerative disorder characterized by loss of striatal neurons, is caused by an expansion of a polyglutamine tract in the HD protein huntingtin. This gene encodes a protein that interacts with the huntingtin-associated protein 1, which is a huntingtin binding protein that may function in vesicle trafficking. [provided by RefSeq, Apr 2016]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -11 ACMG points.

BP4
Computational evidence support a benign effect (REVEL=0.207).
BP6
Variant 3-124228048-G-A is Benign according to our data. Variant chr3-124228048-G-A is described in ClinVar as [Benign]. Clinvar id is 3060740.Status of the report is no_assertion_criteria_provided, 0 stars.
BP7
Synonymous conserved (PhyloP=3.01 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.194 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
KALRNNM_001388419.1 linkc.132G>A p.Lys44Lys synonymous_variant Exon 2 of 60 ENST00000682506.1 NP_001375348.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
KALRNENST00000682506.1 linkc.132G>A p.Lys44Lys synonymous_variant Exon 2 of 60 NM_001388419.1 ENSP00000508359.1 A0A804HLI0

Frequencies

GnomAD3 genomes
AF:
0.0989
AC:
15037
AN:
152036
Hom.:
1129
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.198
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.119
Gnomad ASJ
AF:
0.0513
Gnomad EAS
AF:
0.181
Gnomad SAS
AF:
0.109
Gnomad FIN
AF:
0.0564
Gnomad MID
AF:
0.111
Gnomad NFE
AF:
0.0382
Gnomad OTH
AF:
0.0800
GnomAD2 exomes
AF:
0.0896
AC:
22534
AN:
251414
AF XY:
0.0831
show subpopulations
Gnomad AFR exome
AF:
0.204
Gnomad AMR exome
AF:
0.173
Gnomad ASJ exome
AF:
0.0590
Gnomad EAS exome
AF:
0.183
Gnomad FIN exome
AF:
0.0526
Gnomad NFE exome
AF:
0.0389
Gnomad OTH exome
AF:
0.0779
GnomAD4 exome
AF:
0.0563
AC:
82344
AN:
1461302
Hom.:
3765
Cov.:
30
AF XY:
0.0564
AC XY:
41010
AN XY:
726974
show subpopulations
African (AFR)
AF:
0.216
AC:
7234
AN:
33456
American (AMR)
AF:
0.162
AC:
7265
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.0594
AC:
1552
AN:
26128
East Asian (EAS)
AF:
0.186
AC:
7376
AN:
39688
South Asian (SAS)
AF:
0.104
AC:
8934
AN:
86234
European-Finnish (FIN)
AF:
0.0541
AC:
2890
AN:
53418
Middle Eastern (MID)
AF:
0.0758
AC:
437
AN:
5764
European-Non Finnish (NFE)
AF:
0.0380
AC:
42282
AN:
1111520
Other (OTH)
AF:
0.0724
AC:
4374
AN:
60374
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.460
Heterozygous variant carriers
0
3869
7738
11607
15476
19345
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1912
3824
5736
7648
9560
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0990
AC:
15069
AN:
152154
Hom.:
1132
Cov.:
31
AF XY:
0.101
AC XY:
7514
AN XY:
74398
show subpopulations
African (AFR)
AF:
0.198
AC:
8205
AN:
41486
American (AMR)
AF:
0.119
AC:
1824
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.0513
AC:
178
AN:
3472
East Asian (EAS)
AF:
0.180
AC:
934
AN:
5178
South Asian (SAS)
AF:
0.109
AC:
528
AN:
4822
European-Finnish (FIN)
AF:
0.0564
AC:
597
AN:
10590
Middle Eastern (MID)
AF:
0.122
AC:
36
AN:
294
European-Non Finnish (NFE)
AF:
0.0382
AC:
2598
AN:
68010
Other (OTH)
AF:
0.0801
AC:
169
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.510
Heterozygous variant carriers
0
675
1350
2026
2701
3376
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
164
328
492
656
820
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0684
Hom.:
448
Bravo
AF:
0.109
Asia WGS
AF:
0.176
AC:
610
AN:
3478
EpiCase
AF:
0.0421
EpiControl
AF:
0.0412

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link

Submissions by phenotype

KALRN-related disorder Benign:1
Nov 18, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.47
CADD
Benign
11
DANN
Benign
0.62
PhyloP100
3.0
PromoterAI
0.0020
Neutral
Mutation Taster
=95/5
polymorphism (auto)

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2293641; hg19: chr3-123946895; COSMIC: COSV53753306; API